Fidelity Investments
ASPX

Fidelity Investments’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Fidelity Investments’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,792,398
Closed -$180M – 2893
2015
Q1 		$180M Sell
1,792,398
-2,279,677
-56% -$152M 0.02% 738
2014
Q4 		$214M Buy
4,072,075
+1,452,504
+55% +$42.7M 0.03% 644
2014
Q3 		$67.2M Buy
2,619,571
+260,000
+11% +$5.53M 0.01% 1160
2014
Q2 		$52.5M Buy
2,359,571
+189,671
+9% +$4.15M 0.01% 1318
2014
Q1 		$66.7M Buy
+2,169,900
New +$58.3M 0.01% 1187

Fidelity Investments's ASPX Position: Q2 2015 in Review

Fidelity Investments sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 1,792,398 shares — an estimated $180M sold.

Fidelity Investments first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $214M in Q4 2014. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Fidelity Investments reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Fidelity Investments sold 1,792,398 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $180M.
  • Fidelity Investments first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • Fidelity Investments's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $214M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Fidelity Investments's 13F filing for Q2 2015, filed 13 Aug 2015.